In case you missed it: March 8 to March 12
It was a very busy week for the Contemporary OB/GYN team.
This week’s top articles included:
How insurance impacts access to NIPT
Some women are unable to choose noninvasive prenatal testing (NIPT), due to lack of insurance coverage, according to a pilot study in the Journal of Community Genetics.
Cost of cell-free DNA noninvasive testing for Down syndrome
A small percentage of women whose noninvasive prenatal testing (NIPT) results were negative regretted taking the test and blamed themselves, according to a 1-year postpartum questionnaire survey.
Inclusion necessary in clinical trials
This month’s issue brings with it hope for a spring season that will see an easing of COVID-19 cases and deaths, despite new virus mutations.
Improvements in Research Needed for Reproductive Health of Transgender and Gender Diverse People
The scoping review revealed target areas that require additional research, as well as a need for more variety in study designs, populations, and locations.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
